Over 30 years ago scientists discovered the potential of Gila monster venom as a treatment for type 2 diabetes
J Med Internet Res 22(3):e16791
Drug interactions are relatively uncommon with GLP-1 receptor agonists, but their effect on gastric emptying can delay the absorption of oral medications
In this blog, well explore how GLP-1s may interact with PMDD (premenstrual dysphoric disorder), and how hormonal changes can affect hunger and cravings, potentially influencing weight management efforts
Ultimately, the decision to continue or discontinue GLP-1 treatment after reaching your weight loss goal should be based on a comprehensive assessment of your individual health needs, potential benefits, and any risks associated with long-term use of the medication
Future work should therefore validate key pathways under conditions that better reflect the metabolic context of patients with ASCVD or heart failure